Judge OKs Purdue deal; Sacklers to pay $7B
A U.S. Bankruptcy Court judge said he will issue his reasoning Tuesday for approving Purdue Pharma’s nationwide opioid settlement, which includes up to $7 billion from the Sackler family over 15 years and creates a successor company, Knoa Pharma, overseen by a state‑appointed board. The plan directs most funds to governments for opioid abatement and reserves about $850 million for individual victims, with eligible OxyContin patients and survivors slated to receive payments as soon as next year; those who opt out may still sue Sackler family members.
📌 Key Facts
- Judge Sean Lane accepted the settlement last week and will publish his reasoning Nov. 18, 2025.
- Sackler family to pay up to $7B over 15 years; about $850M set aside for individual victims (estimated ~$8k–$16k per claimant).
- Purdue will be replaced by Knoa Pharma under a board appointed by states; the plan allows non‑opt‑in plaintiffs to sue Sackler family members.